Exclusive Interview with BFM Business Radio: our participation in the BigBooster Program
April 16, 2016
Inauguration meeting with our international scientific board of leading experts to enhance GLUT1DS diagnosis
October 10, 2016
October 7-8, 2016.
[EVENTS] Company ; METAglut1™
We are thrilled to attend the very 1st European Conference on GLUT1 Deficiency, hapenning in Milan thanks to the collaboration of the Glut1 Italian Association and Matthews Friends.
We had the opportunity to introduce METAglut1™ to the european Glut1DS community.
METAglut1™ is our first IVD blood test to aid the early diagnosis of Glut1 Deficiency Syndrom (Glut1DS), also known as De Vivo Disease, a rare neuro metabolic disorder that can significantly impact the lives of affected children.
We believe our diagnostic tool will enable a significant advancement in identifying the condition, leading to profound implcations for patients and their families. And this annual european meeting was the perfect place to share our latest advancements to the Glut1DS community and foster collaborations among the disease’s specialists.
We were very excited for this long-awaited first European meetup focused on GLUT1DS, and we can only hope it will bring together all individual initiatives to raise awareness about the condition. Together, we aim to work as a united European and worldwide community to improve patients’ lives.
By participating in this inaugural European event dedicated to GLUT1DS, we not only increased our visibility but also expanded our network of collaborators and potential customers. This engagement is vital for fostering partnerships that will enhance our efforts in delivering effective diagnostic solutions.
About the event organizer
Matthews Friends are a UK registered charity, operating since 2014 and specializing exclusively in medical ketogenic dietary therapies. They support patients, families and professionals by providing information, training, research and grants to develop ketogenic services and support systems for drug resistant (refractory) epilepsy as well as other neurological and metabolic disorders, such as GlutDS.
The Conference on Glut1 Deficiency, organized by Matthews Friends, was an opportunity for families and professionals to learn together as well as providing access to professionals working in the field of Glut 1 Deficiency by the families.
Participating in the 1st European Conference on GLUT1 Deficiency has invigorated our commitment to advancing research and innovation in pediatric health. We are dedicated to collaborating with experts and stakeholders to improve patient outcomes and have the test as fast as possible covered and available.
